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Background: The ACC/AHA guidelines for management of patients with ST-segment elevation myocardial infarction (STEMI) recommend urgent 
reperfusion therapy for patients with new left bundle branch block (LBBB). However, there are limited contemporary data comparing these two 
groups of patients particularly from the developing countries. Accordingly, we sought to compare the two groups in a multicenter multinational 
registry from the Middle East.
methods: For a period of 9 months in 2008 to 2009, consecutive patients with acute coronary syndromes (ACS) were enrolled from 65 hospitals 
in 6 Middle East countries. Patients presenting with new or presumed new LBBB in this cohort were compared to patients with STEMI. Clinical 
characteristics, management and in-hospital outcomes were examined.
results: Among 7,930 ACS patients enrolled, there were 3432 patients with STEMI and 85 patients with new or presumed new LBBB. Patients with 
LBBB were 10 years older with a significantly higher prevalence of hypertension (48.2% vs.34.2%, P=0.008), and prior myocardial infarction (19.3% 
vs.9.3%, P=0.002), compared with patients with STEMI. Patients with LBBB were significantly less commonly smokers (64.9% vs. 37%, P<0.001) and 
less likely to receive thrombolytic therapy (20.8% vs. 54.5%, P<0.001) whereas primary percutaneous coronary interventions use was equivalent 
among the two groups (13.3% vs. 12.9%, P=0.93). Heart failure was significantly observed more in patients with LBBB (31.8% vs. 13.1%, P<0.001). 
The in-hospital mortality rates were higher for patients with new or presumed new LBBB compared to those with STEMI (14.1% vs. 6.6%, P=0.007). 
After multivariate adjustment, new or presumed new LBBB was an independent predictor of in-hospital mortality (OR 4.42, 95% CI= 2.2-8.7, 
P<0.001).
conclusions: Compared to patients with STEMI, patients with new or presumed new LBBB have significantly more co-morbidities and a higher 
mortality rate. Further research on these high risk patients is warranted to improve survival.
